<p>Paraffin-embedded sections of the liver (n=4 each group) were stained with hematoxylin-eosin (A) or oil red O (B). Micrographs in both panels are representative pictures with original magnification 40X. Foci of inflammatory cells are shown (arrows). (C) Triglycerides were measured in liver and normalized on 500 mg of frozen tissue (n=6 each group). The mRNA levels of pro-inflammatory cytokines TNF-α (D), MCP-1 (E), F4/80 (F), and TGF-β (G) were analyzed by real-time PCR in liver extracts (n=6, each group). *P<0.05, ***P<0.001 <i>vs</i> STD; <sup>#</sup> P<0.05, <sup># #</sup> P<0.01, <sup># # #</sup> P<0.001 <i>vs</i> HFD.</p
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver...
<p>Panels A and B are the results of real-time PCR for HMGB-1 and TLR4, respectively, in liver extra...
Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic l...
<p>Panel A shows a Western blot analysis of PPAR-α expression (n=6 each group). FGF21 mRNA abundance...
Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease. Insulin r...
In obesity-associated non-alcoholic steatohepatitis (NASH), persistent hepatocellular damage and inf...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver...
<p>Panels A and B are the results of real-time PCR for HMGB-1 and TLR4, respectively, in liver extra...
Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic l...
<p>Panel A shows a Western blot analysis of PPAR-α expression (n=6 each group). FGF21 mRNA abundance...
Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease. Insulin r...
In obesity-associated non-alcoholic steatohepatitis (NASH), persistent hepatocellular damage and inf...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...
Metabolic-associated fatty liver disease (MAFLD) starts with hepatic triglyceride accumulation (stea...